Pacific Edge Limited (PEB.AX)
AUD 0.14
(0.0%)
AUD 0.14
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.04 NZD | -19.22% |
| 2023 | -0.03 NZD | -29.07% |
| 2022 | -0.03 NZD | -29.65% |
| 2021 | -0.02 NZD | 38.77% |
| 2020 | -0.03 NZD | 6.88% |
| 2019 | -0.03 NZD | 17.69% |
| 2018 | -0.04 NZD | 19.54% |
| 2017 | -0.05 NZD | -30.12% |
| 2016 | -0.04 NZD | -30.23% |
| 2015 | -0.03 NZD | -5.07% |
| 2014 | -0.03 NZD | -37.04% |
| 2013 | -0.02 NZD | -38.46% |
| 2012 | -0.02 NZD | -4.0% |
| 2011 | -0.02 NZD | -7.91% |
| 2010 | -0.01 NZD | 23.63% |
| 2009 | -0.02 NZD | -25.52% |
| 2008 | -0.01 NZD | 0.0% |
| 2007 | - NZD | 100.0% |
| 2006 | -0.06 NZD | 25.54% |
| 2005 | -0.07 NZD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q4 | -0.01 NZD | 0.0% |
| 2024 Q1 | -0.01 NZD | 6.86% |
| 2024 Q2 | -0.01 NZD | 0.0% |
| 2024 Q3 | -0.01 NZD | 8.42% |
| 2024 FY | - NZD | -19.22% |
| 2023 Q4 | -0.01 NZD | 0.0% |
| 2023 FY | - NZD | -29.07% |
| 2023 Q3 | -0.01 NZD | -56.92% |
| 2023 Q2 | -0.01 NZD | 0.0% |
| 2023 Q1 | -0.01 NZD | 5.8% |
| 2022 Q2 | -0.01 NZD | 0.0% |
| 2022 Q3 | -0.01 NZD | -15.0% |
| 2022 Q4 | -0.01 NZD | 0.0% |
| 2022 FY | - NZD | -29.65% |
| 2022 Q1 | -0.01 NZD | -20.0% |
| 2021 Q2 | -0.01 NZD | 0.0% |
| 2021 Q1 | -0.01 NZD | 32.43% |
| 2021 Q4 | -0.01 NZD | 0.0% |
| 2021 FY | - NZD | 38.77% |
| 2021 Q3 | -0.01 NZD | 0.0% |
| 2020 Q3 | -0.01 NZD | 17.78% |
| 2020 FY | - NZD | 6.88% |
| 2020 Q4 | -0.01 NZD | 0.0% |
| 2020 Q2 | -0.01 NZD | 0.0% |
| 2020 Q1 | -0.01 NZD | 0.0% |
| 2019 Q3 | -0.01 NZD | 5.26% |
| 2019 FY | - NZD | 17.69% |
| 2019 Q1 | -0.01 NZD | 11.21% |
| 2019 Q4 | -0.01 NZD | 0.0% |
| 2019 Q2 | -0.01 NZD | 0.0% |
| 2018 Q1 | -0.01 NZD | 11.11% |
| 2018 FY | - NZD | 19.54% |
| 2018 Q4 | -0.01 NZD | 0.0% |
| 2018 Q2 | -0.01 NZD | 0.0% |
| 2018 Q3 | -0.01 NZD | 10.83% |
| 2017 Q3 | -0.01 NZD | 10.0% |
| 2017 Q4 | -0.01 NZD | 0.0% |
| 2017 FY | - NZD | -30.12% |
| 2017 Q2 | -0.02 NZD | 0.0% |
| 2017 Q1 | -0.02 NZD | -7.14% |
| 2016 FY | - NZD | -30.23% |
| 2016 Q4 | -0.01 NZD | 0.0% |
| 2016 Q1 | -0.01 NZD | 30.33% |
| 2016 Q2 | -0.01 NZD | 0.0% |
| 2016 Q3 | -0.01 NZD | -64.71% |
| 2015 Q4 | -0.01 NZD | 0.0% |
| 2015 FY | - NZD | -5.07% |
| 2015 Q3 | -0.01 NZD | -62.67% |
| 2015 Q2 | -0.01 NZD | 0.0% |
| 2015 Q1 | -0.01 NZD | 12.79% |
| 2014 Q2 | -0.01 NZD | -5.88% |
| 2014 Q1 | -0.01 NZD | -30.77% |
| 2014 FY | - NZD | -37.04% |
| 2014 Q4 | -0.01 NZD | 0.0% |
| 2014 Q3 | -0.01 NZD | 4.44% |
| 2013 Q3 | -0.01 NZD | 0.0% |
| 2013 Q4 | -0.01 NZD | 0.0% |
| 2013 FY | - NZD | -38.46% |
| 2012 FY | - NZD | -4.0% |
| 2011 FY | - NZD | -7.91% |
| 2010 FY | - NZD | 23.63% |
| 2009 FY | - NZD | -25.52% |
| 2008 FY | - NZD | 0.0% |
| 2007 FY | - NZD | 100.0% |
| 2006 FY | - NZD | 25.54% |
| 2005 FY | - NZD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Australian Clinical Labs Limited | 0.12 AUD | 133.083% |
| BCAL Diagnostics Limited | -0.03 AUD | -52.692% |
| Genetic Signatures Limited | -0.11 AUD | 63.909% |
| Genetic Technologies Limited | -0.09 AUD | 56.326% |
| Healius Limited | -0.98 AUD | 95.949% |
| Imagion Biosystems Limited | -0.41 AUD | 90.317% |
| Integral Diagnostics Limited | -0.26 AUD | 84.731% |
| INOVIQ Ltd | -0.07 AUD | 44.006% |
| Microba Life Sciences Limited | -0.05 AUD | 18.313% |
| Monash IVF Group Limited | -0.02 AUD | -136.31% |
| Rhythm Biosciences Limited | -0.03 AUD | -32.333% |
| Sonic Healthcare Limited | 1.07 AUD | 103.71% |